Azanta is an international specialty biopharmaceutical company developing treatments for women's health indications and for orphan oncology. Our lead product is Angusta®. To support our operations and to subsidize our development of Nimoral and Angusta® and other orphan oncology and women's health care product candidates, we currently market and distribute a portfolio of specialty pharmaceuticals products pursuant to third party distribution agreements.  Constantly, Azanta looks for new licensing opportunities and partners with products to supplement and broaden the products in our existing portfolio that at the same time addresses unmet treatment needs.  

Click here 

Azanta mission:

Because life matters


Azanta A/S, Gearhalsvej 1, DK-2500 Valby, Denmark, Phone +45 7025 9545, Fax: +45 7025 9546, Mail:

DisclaimerAll rights reserved ©